Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Delcath Systems Inc DCTH

Healthcare Medical Devices
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company’s lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical... see more

Current News (NDAQ:DCTH)

Delcath Systems Announces Publication of 10-Year Single-Center Experience with Percutaneous Hepatic Perfusion in Liver-Dominant Metastatic Uveal Melanoma

Business Wire 3 days ago

Delcath Systems Board of Directors Authorizes $25 Million Share Repurchase Program

Business Wire November 20, 2025

Delcath Systems Announces Publication of Expert Narrative Review on Percutaneous Hepatic Perfusion for Liver Metastases from Uveal Melanoma

Business Wire November 18, 2025

Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire November 14, 2025

Delcath Systems Announces Publication of Real-World Evidence Supporting Early Use of Liver-Directed Therapy with PHP in Achieving Long-Term Survival for Metastatic Uveal Melanoma Patients

Business Wire November 13, 2025

Delcath Systems to Participate in Upcoming Investor Conferences

Business Wire November 6, 2025

Delcath Systems Reports Third Quarter 2025 Results and Business Highlights

Business Wire November 4, 2025

Delcath Systems to Host Third Quarter 2025 Earnings Call

Business Wire October 21, 2025

Delcath Systems Announces Preliminary Third Quarter 2025 Financial Results

Business Wire October 18, 2025
View More News ››

Opinion & Analysis (NDAQ:DCTH)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:DCTH)

Delcath Systems (DCTH): Pioneering Liver-Directed Cancer The

Huge potential here. DCTH just got FDA approval for HEPZATO KIT and crushed Q3 with $11.2M revenue - that's a 2,481% YoY jump. Gross...
MikeTester - January 24, 2025

RE:Things are going ok

Actually 3.5 year highs
ofnid - January 18, 2025

Things are going ok

Another quarter of excellent performance. Their pre release showed that revenues are on track, the stock making new 4 year highs shows...
ofnid - January 18, 2025

RE:Delcath Systems (DCTH): Ready to Pop or Flop?

I will disagree strongly on your assessment if they nail the trial results. If they do, this stock will be worth many, many times its...
TheRexmember - December 16, 2024

Delcath Systems (DCTH): Ready to Pop or Flop?

DCTH’s recent buzz has oncology traders salivating, but here’s the rub: their treatments are niche, and scaling that is no joke. If they...
Trader19Swift - December 2, 2024

Worth a look

Well it has been a long time but DCTH has performed and is ramping up it's revenues and helping people live longer with a deadly...
ofnid - November 3, 2024
View more Bullboard ››

Kobrea Exploration Corp.

Kobrea Exploration Corp.

Kobrea Exploration Corp. engages in the acquisition, exploration, and evaluation of mineral properties in Canada. It holds a ...
View More »